127 related articles for article (PubMed ID: 1685517)
1. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies.
Panchagnula R; Ritschel WA
J Pharm Pharmacol; 1991 Sep; 43(9):609-14. PubMed ID: 1685517
[TBL] [Abstract][Full Text] [Related]
2. Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot.
Ritschel WA; Panchagnula R; Stemmer K; Ashraf M
Skin Pharmacol; 1991; 4(4):235-45. PubMed ID: 1789985
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations.
Mura P; Faucci MT; Bramanti G; Corti P
Eur J Pharm Sci; 2000 Feb; 9(4):365-72. PubMed ID: 10664476
[TBL] [Abstract][Full Text] [Related]
4. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P.
Lee SG; Kang JB; Kim SR; Kim CJ; Yeom DW; Yoon HY; Kwak SS; Choi YW
Drug Dev Ind Pharm; 2016 Oct; 42(10):1636-42. PubMed ID: 26925849
[TBL] [Abstract][Full Text] [Related]
5. Possibilities of the microemulsion use as indomethacin solubilizer and its effect on
Špaglová M; Čuchorová M; Šimunková V; Matúšová D; Čierna M; Starýchová L; Bauerová K
Drug Dev Ind Pharm; 2020 Sep; 46(9):1468-1476. PubMed ID: 32715801
[TBL] [Abstract][Full Text] [Related]
6. The effect of diethylene glycol monoethyl ether as a vehicle for topical delivery of ivermectin.
Yazdanian M; Chen E
Vet Res Commun; 1995; 19(4):309-19. PubMed ID: 8540242
[TBL] [Abstract][Full Text] [Related]
7. Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations.
Fini A; Bergamante V; Ceschel GC; Ronchi C; De Moraes CA
AAPS PharmSciTech; 2008; 9(3):762-8. PubMed ID: 18563577
[TBL] [Abstract][Full Text] [Related]
8. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions.
Pireddu R; Sinico C; Ennas G; Schlich M; Valenti D; Murgia S; Marongiu F; Fadda AM; Lai F
Colloids Surf B Biointerfaces; 2018 Feb; 162():8-15. PubMed ID: 29132043
[TBL] [Abstract][Full Text] [Related]
9. Preparation and In Vitro and In Vivo Evaluation of a Testosterone Film Forming Gel for the Treatment of Hypoactive Sexual Desire Disorder in Women.
Zeng J; Xie TF; Huang T; Li F; Wang ZP; Feng LL
AAPS PharmSciTech; 2022 Feb; 23(3):79. PubMed ID: 35212788
[TBL] [Abstract][Full Text] [Related]
10. Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products.
Osborne DW
J Cosmet Dermatol; 2011 Dec; 10(4):324-9. PubMed ID: 22151944
[TBL] [Abstract][Full Text] [Related]
11. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage.
Cevc G; Blume G
Biochim Biophys Acta; 2004 May; 1663(1-2):61-73. PubMed ID: 15157608
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine.
Baboota S; Al-Azaki A; Kohli K; Ali J; Dixit N; Shakeel F
PDA J Pharm Sci Technol; 2007; 61(4):276-85. PubMed ID: 17933209
[TBL] [Abstract][Full Text] [Related]
13. Effect of formulation factors on penetration of hydrocortisone through mouse skin.
Shahi V; Zatz JL
J Pharm Sci; 1978 Jun; 67(6):789-92. PubMed ID: 660457
[TBL] [Abstract][Full Text] [Related]
14. Skin Penetration and Permeation Properties of Transcutol®-Neat or Diluted Mixtures.
Osborne DW; Musakhanian J
AAPS PharmSciTech; 2018 Nov; 19(8):3512-3533. PubMed ID: 30421383
[TBL] [Abstract][Full Text] [Related]
15. Different approaches for improving skin accumulation of topical corticosteroids.
Senyiğit T; Padula C; Ozer O; Santi P
Int J Pharm; 2009 Oct; 380(1-2):155-60. PubMed ID: 19635541
[TBL] [Abstract][Full Text] [Related]
16. In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: effect of Azone and Transcutol.
Escobar-Chávez JJ; Quintanar-Guerrero D; Ganem-Quintanar A
Drug Dev Ind Pharm; 2005 May; 31(4-5):447-54. PubMed ID: 16093210
[TBL] [Abstract][Full Text] [Related]
17. Formulation and ex vivo evaluation of rofecoxib gel for topical application.
Das MK; Ahmed AB
Acta Pol Pharm; 2007; 64(5):461-7. PubMed ID: 18540168
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream.
Sankar V; Praveen C; Prasanth KG; Srinivas CR; Ruckmann K
Pharmazie; 2009 Nov; 64(11):731-4. PubMed ID: 20099517
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
20. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.
Whitaker M; Debono M; Huatan H; Merke D; Arlt W; Ross RJ
Clin Endocrinol (Oxf); 2014 Apr; 80(4):554-561. PubMed ID: 23980724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
